New Game

CSF77

Well-known member
Joined:
Apr 16, 2013
Posts:
17,955
Liked Posts:
2,775
Location:
San Diego
k so you agree with me then that we should move everyone on the roster that can net a return of any kind?

No

I feel that as the season goes on MLB will relax the restrictions to attendance. Shoot most of the people that I work with including myself are vaccinated. So this is just a time game that we are going through.

So if we know anything about Tom is he will spend with in a budget. The loss of fans forced a payroll reduction. A increase of fans will increase payroll.

So that is a opinion based off of Tom's history with the team. He diverted funds to rebuild infrastructure. Then payroll shot up. Then he bought up real estate to absorb the seating in the buildings to again generate more revenue. Then a new TV deal to increase revenue.

So the notion that he dumps payroll? No.

I see it as a very basic relationship. Tom gives Jed a working payroll. Jed is 100% responsible to fill it and 100% accountable of the results of those decisions.

so if the team fails then yes it makes business sense to sell off assets and reinvest into system depth.

but going into 2022 does that mean that Tom tightens up his purse strings? No. If you look above responsibility and accountability falls on Jed. If Jed screws up like trades Bryant for a garbage return and he goes on to win a WS and hits the market on a mega deal that would have scored a far better talent than what Jed accepted in July that reflects poorly on Jed. Would it fire him? Most likely not but if it becomes a business trend of selling at lower than market value (Darvish) then yes he would have to fire him and bring in a new person with a new vision.
 

CSF77

Well-known member
Joined:
Apr 16, 2013
Posts:
17,955
Liked Posts:
2,775
Location:
San Diego
So short answer? We will know it in June. The season dictates those decisions.

Speculation is fine. But I would rather have a solid season and Jed lets Bryant Baez and Rizzo walk. Get his 3 QO's and then invest into next year's payroll with the freed up assets.

Should he sell high on Contreras'? No because of Jed's trade history. It sucks. But that is a personal opinion. Even if he gets a studs quality talent he is giving up a studs talent. If Jed instead extends Wilson? He has a complete game right now in a vital position. He can put the team on his back. Cards paid Yadi and built around him because he was that important to their brand.

If Jed did trade him and got another garbage return...for fuck's sake why would you trust him after he hosed up the Darvish deal.
 

knoxville7

I have the stride of a gazelle
CCS Hall of Fame '22
Joined:
Jul 12, 2013
Posts:
16,529
Liked Posts:
12,955
Location:
The sewers
My favorite teams
  1. Chicago Cubs
  1. Chicago Bulls
  1. Chicago Bears
  1. Tennessee Volunteers
Oh vaccines?! You mean the ones that don’t work against the new mutations?! It’s not a vaccine anyways, people need to stop calling it that. It’s more a booster shot. Something you’ll have to get every year. So if you’re banking on that as the reasoning for attendance bouncing back come June, you’re going to be sadly mistaken

and then you go on some rant that really has nothing to do with my point. I’m claiming the quickest way back to relevancy is to trade away everyone this season and start from scratch. You’re claiming they would be better off dumping money into some of these bums and then going out and signing Trevor story. So you must like mediocrity cuz we aren’t going to compete for much by going that route
 

Chicagosports89

Well-known member
Joined:
Mar 31, 2018
Posts:
14,269
Liked Posts:
20,422
Oh vaccines?! You mean the ones that don’t work against the new mutations?! It’s not a vaccine anyways, people need to stop calling it that. It’s more a booster shot. Something you’ll have to get every year. So if you’re banking on that as the reasoning for attendance bouncing back come June, you’re going to be sadly mistaken

and then you go on some rant that really has nothing to do with my point. I’m claiming the quickest way back to relevancy is to trade away everyone this season and start from scratch. You’re claiming they would be better off dumping money into some of these bums and then going out and signing Trevor story. So you must like mediocrity cuz we aren’t going to compete for much by going that route
It absolutely is a vaccine and I'm sure boosters will be needed but nobody has any clue how often until that time comes. But also that point has nothing to do with the fact the cubs should trade anybody they can get value for
 

knoxville7

I have the stride of a gazelle
CCS Hall of Fame '22
Joined:
Jul 12, 2013
Posts:
16,529
Liked Posts:
12,955
Location:
The sewers
My favorite teams
  1. Chicago Cubs
  1. Chicago Bulls
  1. Chicago Bears
  1. Tennessee Volunteers
It absolutely is a vaccine and I'm sure boosters will be needed but nobody has any clue how often until that time comes. But also that point has nothing to do with the fact the cubs should trade anybody they can get value for

I mean, one of the “vaccine” companies has recently come out and said you’re likely to need a booster shot within the first year. The notion that Wrigley could be anywhere near full by June is crazy at a time when we are seeing a peak in hospitalizations. But yes, it doesn’t have much to do with the need to sell off any players they can. It’s my bad for falling into the rabbit hole he created by diverting the conversation
 

Chicagosports89

Well-known member
Joined:
Mar 31, 2018
Posts:
14,269
Liked Posts:
20,422
I mean, one of the “vaccine” companies has recently come out and said you’re likely to need a booster shot within the first year. The notion that Wrigley could be anywhere near full by June is crazy at a time when we are seeing a peak in hospitalizations. But yes, it doesn’t have much to do with the need to sell off any players they can. It’s my bad for falling into the rabbit hole he created by diverting the conversation
I think that booster is actually for the variants though.
 

knoxville7

I have the stride of a gazelle
CCS Hall of Fame '22
Joined:
Jul 12, 2013
Posts:
16,529
Liked Posts:
12,955
Location:
The sewers
My favorite teams
  1. Chicago Cubs
  1. Chicago Bulls
  1. Chicago Bears
  1. Tennessee Volunteers
Last edited:

CSF77

Well-known member
Joined:
Apr 16, 2013
Posts:
17,955
Liked Posts:
2,775
Location:
San Diego
Johnson & Johnson’s Janssen COVID-19 vaccine is a viral vector vaccine. Viral vector vaccines use a modified version of a different, harmless virus (the vector) to deliver important instructions to our cells to start building protection. The instructions are delivered in the form of genetic material. This material does not integrate into a person’s DNA. These instructions tell the cell to produce a harmless piece of virus that causes COVID-19. This is a spike protein and is only found on the surface of the virus that causes COVID-19. This triggers our immune system to recognize the virus that causes COVID-19 and to begin producing antibodies and activating other immune cells to fight off what it thinks is an infection. Learn more about how viral vector vaccines work.
 

CSF77

Well-known member
Joined:
Apr 16, 2013
Posts:
17,955
Liked Posts:
2,775
Location:
San Diego
Vaccine
OUR SCIENCE/ The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
January 6, 2021
The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see EUA Fact Sheet at www.cvdvaccine.com.
The U.S. FDA authorization of the Pfizer-BioNTech COVID-19 vaccine for emergency use is a significant step forward in our fight against this pandemic. As we begin to distribute our vaccine, here are some key facts and answers to common questions.
  1. What are the ingredients in the Pfizer-BioNTech COVID-19 vaccine?
The Pfizer BioNTech COVID-19 vaccine is a messenger RNA (mRNA) vaccine that has both synthetic, or chemically produced, components and enzymatically produced components from naturally occurring substances such as proteins. The vaccine does not contain any live virus. Its inactive ingredients include potassium chloride, monobasic potassium, phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose, as well as small amounts of other ingredients.https://www.pfizer.com/news/hot-topics/the_facts_about_pfizer_and_biontech_s_covid_19_vaccine#_edn1 For more information, please visit cvdvaccine.com.
  1. Do mRNA vaccines change a person’s DNA?
No, mRNA is a transient carrier of information that does not integrate into human DNA.[ii],[iii],[iv],[v]
Unlike a traditional vaccine that uses inactivated, dead, or portions of actual virus to spur an immune response, mRNA delivers a message to your body’s cells via a lipid nanoparticle envelope that instructs the cells to generate the spike protein found on the surface of a coronavirus that initiates infection.[vi],[vii] Instructing cells to generate the spike protein spurs an immune response, including generation of antibodies specific to the SARS-CoV-2 spike protein.
  1. Does your vaccine cause infertility?
There are no data to suggest that the Pfizer-BioNTech COVID-19 vaccine causes infertility. It has been incorrectly suggested that COVID-19 vaccines will cause infertility because of a very short amino acid sequence in the spike protein of SARS-CoV-2 that is partly shared with a protein in the placenta called syncytin-1. From a scientific perspective, the differences between the two sequences are quite significant, making it very unlikely our vaccine could generate a response that would harm the placenta.[viii],[ix]
  1. What about allergies and the Pfizer-BioNTech COVID-19 vaccine?
In line with CDC recommendations, we did not test our vaccine in people with a history of severe adverse or allergic reactions to a vaccine or a vaccine ingredient. Overall, there were no safety signals of concern identified in our clinical trials, meaning there was no signal of any serious allergic reaction.https://www.pfizer.com/news/hot-topics/the_facts_about_pfizer_and_biontech_s_covid_19_vaccine#_edn10
Severe allergic reactions have been reported following the Pfizer-BioNTech COVID-19 Vaccine during mass vaccination outside of clinical trials. Pfizer is monitoring and reviewing all reports of severe allergic reaction in coordination with health authorities. The prescribing information has a clear warning/precaution that appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.[ii] You can also find the latest guidance from the CDC here.
  1. Can your vaccine cause people to develop COVID-19?
No. Pfizer and BioNTech’s COVID-19 vaccine is an mRNA vaccine, which does not use the live virus but rather a small portion of the viral sequence of the SARS-CoV-2 virus to instruct the body to produce the spike protein displayed on the surface of the virus. That spike protein then generates an immune response to the virus to potentially prevent infection. The vaccine does not allow the SARS-CoV-2 virus to replicate and it cannot cause any known illness.[x] No vaccine can cause a patient to develop the disease against which they were vaccinated.[xi]
Potential side effects of the Pfizer-BioNTech COVID-19 vaccine include injection site pain, fatigue, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, malaise, and lymphadenopathy (enlargement of the lymph nodes).[xii]
  1. How long will you be watching people who have been vaccinated? How do we know that bad side effects can’t happen long after vaccination, if the vaccine’s only been studied for less than a year?
We will track participants in our phase 3 clinical trial for the next two years following their second dose, in order to document the long-term effectiveness and safety of the vaccine.[xiii]
Our trial is closely monitored by Pfizer and an outside, independent group of experts called a Data Monitoring Committee, or DMC. Trial investigators also monitor participants’ health, and participants in the trial attend regular planned follow-up visits as part of the trial. Pfizer and BioNTech will be conducting additional studies to determine how effective and safe the vaccine is in the real world and among specific risk groups such as healthcare workers and among nursing home residents. The safety of patients is and always will be our number one priority.[xiv]
  1. What can you share about the Pfizer-BioNTech COVID-19 vaccine in pregnant women?
We recognize that developing a potential vaccine for the prevention of COVID-19 for broad use is critically important to combat the pandemic. In line with standard research practice, pregnant women were not enrolled in our trial, so available data on the Pfizer-BioNTech COVID-19 vaccine administered to pregnant women are limited.
However, a recent study in JAMA Network Open compared the outcomes of pregnancies in women that have / have not had SARS-CoV-2 infection, which showed that SARS-CoV-2 infection during pregnancy was not associated with adverse pregnancy outcomes.[xv]
We will evaluate the vaccine in pregnant women in a study starting in Q1 2021, once developmental and reproductive toxicity studies are complete. People who are pregnant or breastfeeding should discuss their vaccination options with their individual health care provider.
  1. When will you be able to share more information about vaccinating those in younger age groups (12-15 and 16-17 years of age)?
We currently have about 1000 participants in the 12-15-year-old age group enrolled in our trial. This controlled approach was agreed to with the FDA to allow for initial safety assessment in a small group. We plan to evaluate and assess these participants after their second dose prior to conducting further enrollment in this age group. Enrollment for 16-17-year old participants will continue as planned and we will share data in due course over the next few months.[xvi]
  1. Does Pfizer and BioNTech’s vaccine cause Bell’s palsy?
Bell’s palsy is a condition that affects the nerves controlling facial muscles and can occur after a viral infection. It is typically temporary and resolves in a few weeks.[xvii] The observed frequency of reported Bell’s palsy in the vaccine group is consistent with the expected background rate in the general population, and there is no indication of a causal relationship at this time. Pfizer and BioNTech together with FDA will continue to monitor for cases of Bell’s palsy as the vaccine is given to larger populations.
 

CSF77

Well-known member
Joined:
Apr 16, 2013
Posts:
17,955
Liked Posts:
2,775
Location:
San Diego
Well biden said 200M vax doses were delivered.

I think that we are doing pretty good in 100 days.

The US has been cruising on vaccines. Biden proudly announced Wednesday that the country has put 200 million shots in American arms during his administration. More than a quarter of the country has been fully vaccinated and 40% has gotten one shot. More than half the population over the age of 18 has gotten one shot.


The issue will be the psycho paranoid anti-vax idiots claiming the moon will hit the earth because the earth will pull from orbit after 100% because that is what the Q lord said 2 weeks ago.

So get in your bunkers with your semi automatics. Pull down your sleeves and shoot any revenuers that get in your cross hairs.
 

Top